Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone in Bipolar Depression
NCT00512616Phase 2Withdrawn
- Sponsor
- National Institute of Mental Health
- Start
- Aug 2007
- Primary completion
- Sep 2009
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of ceftriaxone in bipolar disorder (BD), sponsored by National Institute of Mental Health. Planned start Aug 2007; status: withdrawn.
02
Drugs
ceftriaxone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00512616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512616.